Featured Cancer Clinical Trials

Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies.

A Phase II study of the efficacy and safety of Axitinib given on an individualized schedule for metastatic renal cell cancer after treatment with PD-1 or PD-l1 inhibitor
CASE 7815
View full trial information.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Leukemia, Chronic Myelomonocytic (CMML)
A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia
KURA 1916
View full trial information.

Paroxysmal Nocturnal Hemoglobinuria (PNH)
A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Complement Inhibitor-Naïve Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
View full trial information.

p53/p16-Independent Epigenetic Therapy with Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
CASE 1416
View full trial information.

Advertising Policy

Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies.